Skip to content

Laser Vision Correction Use of an Eye Shield for Maintaining Vision and Mitigating Pain

Laser Vision Correction Use of an Eye Shield for Maintaining Vision and Mitigating Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01675375
Enrollment
125
Registered
2012-08-29
Start date
2012-03-31
Completion date
2013-02-28
Last updated
2013-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Laser Vision Correction Pain and Discomfort

Brief summary

The purpose of this research is to determine if an investigational thin shield can effectively reduce discomfort following Laser Vision Correction.

Interventions

one application following refractive surgery

Sponsors

FORSIGHT Vision3
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients scheduled to undergo Laser Vision Correction for correction of refractive error * FDA approved treatment guidelines for Laser Vision Correction * Age 18-60 * Patients able to understand the requirements of the study, willing to follow study instructions, provide written informed consent to participate, and comply with all study requirements, including the required study follow-up visits

Exclusion criteria

* Any other anterior segment abnormality other than that associated with LAser Vision Correction * Any abnormalities associated with the eye lids * Uncontrolled blepharitis or dry eye * Prior laser treatment of the retina * Any ophthalmic surgery performed within three (3) months prior to study excluding PRK or LASIK * Diagnosis of glaucoma * Active diabetic retinopathy * Clinically significant inflammation or infection within six (6) months prior to study * Uncontrolled systemic disease (e.g., diabetes, hypertension, etc.) in the opinion of the Investigator * Participation in any study involving an investigational drug within the past 30 calendar days, or ongoing participation in a study with an investigational material * Intolerance or hypersensitivity to topical anesthetics, antibiotics, steroids or any other pharmaceuticals that may be used pre and post surgically * Specifically known intolerance or hypersensitivity to contact lenses or any component of the investigative material * A medical condition, serious concurrent illness, or extenuating circumstance that would significantly decrease study compliance, including all prescribed follow-up * Any condition that, in the opinion of the investigator, would jeopardize the safety of the patient * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Evidence of maintaining vision and mitigating pain post Laser Vision Correction using an Eye Shield1yrEvidence of maintaining vision and mitigating pain post Laser Vision Correction using an Eye Shield by subjective patient questionnaires and objective imaging and slit lamp examination.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026